Comparing the Outcomes of Adults with Enterobacteriaceae Bacteremia Receiving Short-Course Versus Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score-Matched Cohort

Clinical Infectious Diseases

Volumn 66, Issue 2, 2018, Pages 172-177

  Chotiprasitsakul, Darunee ^a   Han, Jennifer H ^b   Cosgrove, Sara E ^c   Harris, Anthony D ^d   Lautenbach, Ebbing ^b   Conley, Anna T ^d   Tolomeo, Pam ^b   Wise, Jacqueleen ^b   Tamma, Pranita D ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

antibiotics; duration of therapy; gram negative bacteremia; multidrug resistant

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; SULTAMICILLIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ALL CAUSE MORTALITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; BACTERIAL SKIN DISEASE; BILIARY TRACT INFECTION; BLOOD CULTURE; BLOODSTREAM INFECTION; CATHETER INFECTION; CITROBACTER; CLINICAL OUTCOME; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI INFECTION; FEMALE; GASTROINTESTINAL INFECTION; GRAM NEGATIVE SEPSIS; HUMAN; KLEBSIELLA INFECTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROPENSITY SCORE; PROTEUS INFECTION; RECURRENT INFECTION; RETROSPECTIVE STUDY; SERRATIA INFECTION; SHORT COURSE THERAPY; SOFT TISSUE INFECTION; TREATMENT DURATION; URINARY TRACT INFECTION; ADOLESCENT; BACTEREMIA; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; RECURRENT DISEASE; SURVIVAL ANALYSIS; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPENSITY SCORE; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85040634489     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix767     Document Type: Article

References (19)

1. Suljagić V, Cobeljić M, Janković S, et al. Nosocomial bloodstream infections in ICU and non-ICU patients. Am J Infect Control 2005; 33:333-40.
2. Cunha BA. Antibiotic side effects. Med Clin North Am 2001; 85:149-85.
3. Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med. 2017; 177:1308-15.
4. Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 2004; 10:S122-9.
5. Corona A, Wilson AP, Grassi M, Singer M. Prospective audit of bacteraemia management in a university hospital ICU using a general strategy of short-course monotherapy. J Antimicrob Chemother 2004; 54:809-17.
6. Corey GR, Stryjewski ME, Everts RJ. Short-course therapy for bloodstream infections in immunocompetent adults. Int J Antimicrob Agents 2009; 34(suppl 4):S47-51.
7. Havey TC, Fowler RA, Pinto R, et al. Duration of antibiotic therapy for critically ill patients with bloodstream infections: A retrospective cohort study. Can J Infect Dis Med Microbiol 2013; 24:129-37.
8. Havey TC, Fowler RA, Daneman N. Duration of antibiotic therapy for bacteremia: A systematic review and meta-Analysis. Crit Care 2011; 15:R267.
9. Centers for Disease Control and Prevention. Antimicrobial resistant phenotype definitions. Available at: http://www.cdc.gov/nhsn/pdfs/ps-Analysis-resources/phenotype-definitions.pdf. Accessed 9 April 2017.
10. Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013; 108:478-98; quiz 499.
11. Rhee JY, Kwon KT, Ki HK, et al. Scoring systems for prediction of mortality in patients with intensive care unit-Acquired sepsis: A comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock 2009; 31:146-150.
12. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:1-45.
13. Corona A, Bertolini G, Ricotta AM, Wilson A, Singer M, Wilson A. Variability of treatment duration for bacteraemia in the critically ill: A multinational survey. J Antimicrob Chemother 2003; 52:849-52.
14. File TM Jr. Duration and cessation of antimicrobial treatment. J Hosp Med 2012; 7(suppl 1):S22-33.
15. Hayashi Y, Paterson DL. Strategies for reduction in duration of antibiotic use in hospitalized patients. Clin Infect Dis 2011;52:1232-40.
16. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000; 162:505-11.
17. Tamma PD, Turnbull AE, Milstone AM, Lehmann CU, Sydnor ER, Cosgrove SE. Ventilator-Associated tracheitis in children: does antibiotic duration matter? Clin Infect Dis 2011; 52:1324-31.
18. Chastre J, Wolff M, Fagon JY, et al; PneumA Trial Group. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-Associated pneumonia in adults: A randomized trial. JAMA 2003; 290:2588-98.
19. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-Analysis. BMJ 2010; 340:c2096.